UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Aggressive B cell lymphomas—highlights from ASH 2022

Memo - Magazine of European medical oncology, 2023-09, Vol.16 (3), p.149-151

Panny, Michael

2023

Volltextzugriff (PDF)

ASH 2018—aggressive lymphoma

Memo - Magazine of European medical oncology, 2019-09, Vol.12 (3), p.207-211

Panny, Michael

2019

Volltextzugriff (PDF)

Hodgkin lymphoma—how much therapy do we need?

Memo - Magazine of European medical oncology, 2023-02, Vol.16 (1), p.6-9

2023

Volltextzugriff (PDF)

Facial Diplegia as Initial Manifestation of Acute, Myelomonocytic Leukemia with Isolated Trisomy 47, XY,+11[14]/46, XY[6]

Journal of neurosciences in rural practice, 2017-07, Vol.8 (3), p.451-454

2017

Volltextzugriff (PDF)

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Cancer discovery, 2022-02, Vol.12 (2), p.372-387

2022

Volltextzugriff (PDF)

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Blood, 2017-12, Vol.130 (23), p.2499-2503

2017

Volltextzugriff (PDF)

Treatment of High Risk Aggressive B Cell Lymphomas with DA EPOCH R- a Retrospective Analysis

Blood, 2016-12, Vol.128 (22), p.5413-5413

2016

Volltextzugriff (PDF)

Autologous Stem Cell Transplantation with Benda-Eam (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin´s Lymphoma

Blood, 2016-12, Vol.128 (22), p.2265-2265

2016

Volltextzugriff (PDF)

DA-EPOCH-R: An alternative treatment for high-risk diffuse large B cell lymphoma?: Treatment intensity and outcome in newly diagnosed myeloma patients

Memo - Magazine of European medical oncology, 2016-12, Vol.9 (4), p.178-182

2016

Volltextzugriff (PDF)

High‐dose Bendamustine‐EAM followed by autologous stem cell rescue results in long‐term remission rates in lymphoma patients, without renal toxicity

European journal of haematology, 2018-09, Vol.101 (3), p.326-331

2018

Volltextzugriff (PDF)

A Randomized Phase II Trial Comparing BeEAM with BEAM As Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma Patients

Blood, 2022-11, Vol.140 (Supplement 1), p.1180-1182

2022

Volltextzugriff (PDF)

Long-Time Follow-up of 888 Patients Diagnosed with CLL on a Single Center: Comorbidities, Time-to-Treatment and Comparison between Treated and Untreated Patients

Blood, 2019-11, Vol.134 (Supplement_1), p.5458-5458

2019

Volltextzugriff (PDF)

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30‐positive aggressive lymphomas

European journal of haematology, 2020-03, Vol.104 (3), p.251-258

2020

Volltextzugriff (PDF)

Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

Blood, 2020-11, Vol.136 (Supplement 1), p.2-4

2020

Volltextzugriff (PDF)

Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients

Memo - Magazine of European medical oncology, 2015-04, Vol.8 (1), p.22-25

2015

Volltextzugriff (PDF)

BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial

EClinicalMedicine, 2023-12, Vol.66, p.102318-102318, Article 102318

2023

Volltextzugriff (PDF)

Angio-Seal Use in Patients with Peripheral Arterial Disease (ASPIRE)

Angiology, 2009-10, Vol.60 (5), p.536-538

2009

Volltextzugriff (PDF)

Severity of chronic venous disorders and its relationship to the calf muscle pump

VASA, 2009-05, Vol.38 (2), p.171

2009

Volltextzugriff (PDF)

Facial Diplegia as Initial Manifestation of Acute, Myelomonocytic Leukemia with Isolated Trisomy 47, XY,+11[14]/46, XY[6]

Journal of neurosciences in rural practice, 2017, Vol.8 (3), p.451-454

2017

Volltextzugriff (PDF)

PERK Is Critical for Alphavirus Nonstructural Protein Translation

Viruses, 2021-05, Vol.13 (5), p.892

2021

Volltextzugriff (PDF)

A Pilot Study of Ketamine Infusion after Suicide Attempt: New Frontiers in Treating Acute Suicidality in a Real-World Medical Setting

International journal of environmental research and public health, 2022-10, Vol.19 (21), p.13792

2022

Volltextzugriff (PDF)

Ketamine Infusion After Suicide Attempt: New Frontiers in Treating Acute Suicidality in a “real world” Medical Setting

Journal of the Academy of Consultation-Liaison Psychiatry, 2022-05, Vol.63, p.S106-S107

2022

Volltextzugriff (PDF)

Disorientation Faults in CSIDH

Advances in Cryptology – EUROCRYPT 2023, 2023, Vol.LNCS-14008, p.310-342

2023

Volltextzugriff (PDF)

Beyond Price - Assessing the Impact of Non-Price Criteria in Solar Photovoltaic Auctions

2024 20th International Conference on the European Energy Market (EEM), 2024, p.1-8

2024

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Humans
(10)
Male
(8)
Adult
(7)
Female
(7)
Middle Aged
(7)
Aged
(6)
Oncology
(6)
Medicine
(5)
Medicine & Public Health
(5)
Medicine/public Health
(5)
Short Review
(5)
Lymphoma
(4)
Treatment Outcome
(4)
Young Adult
(4)
Adolescent
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Bendamustine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Aggressive B cell lymphomas—highlights from ASH 2022

ASH 2018—aggressive lymphoma

Hodgkin lymphoma—how much therapy do we need?

Facial Diplegia as Initial Manifestation of Acute, Myelomonocytic Leukemia with Isolated Trisomy 47, XY,+11[14]/46, XY[6]

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia

Treatment of High Risk Aggressive B Cell Lymphomas with DA EPOCH R- a Retrospective Analysis

Autologous Stem Cell Transplantation with Benda-Eam (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin´s Lymphoma

DA-EPOCH-R: An alternative treatment for high-risk diffuse large B cell lymphoma?: Treatment intensity and outcome in newly diagnosed myeloma patients

High‐dose Bendamustine‐EAM followed by autologous stem cell rescue results in long‐term remission rates in lymphoma patients, without renal toxicity

A Randomized Phase II Trial Comparing BeEAM with BEAM As Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma Patients

Long-Time Follow-up of 888 Patients Diagnosed with CLL on a Single Center: Comorbidities, Time-to-Treatment and Comparison between Treated and Untreated Patients

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30‐positive aggressive lymphomas

Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial

The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)

Is more better in myeloma? Treatment intensity and outcome in newly diagnosed myeloma patients

BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial

Angio-Seal Use in Patients with Peripheral Arterial Disease (ASPIRE)

Severity of chronic venous disorders and its relationship to the calf muscle pump

Facial Diplegia as Initial Manifestation of Acute, Myelomonocytic Leukemia with Isolated Trisomy 47, XY,+11[14]/46, XY[6]

PERK Is Critical for Alphavirus Nonstructural Protein Translation

A Pilot Study of Ketamine Infusion after Suicide Attempt: New Frontiers in Treating Acute Suicidality in a Real-World Medical Setting

Ketamine Infusion After Suicide Attempt: New Frontiers in Treating Acute Suicidality in a “real world” Medical Setting

Disorientation Faults in CSIDH

Beyond Price - Assessing the Impact of Non-Price Criteria in Solar Photovoltaic Auctions

Suchergebnisse filtern